ChemicalBook >> CAS DataBase List >>Enviomycin

Enviomycin

CAS No.
33103-22-9
Chemical Name:
Enviomycin
Synonyms
Turn-n;enviomucin;Aids008855;Enviomycin;Aids-008855;Tuberactinomycin N;Tuberactin (*sulfate*);Tuberactinomycin N (8CI, 9CI);1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv.;1-(L-Threo-3,6-diamino-4-hydroxy-hexanoic acid)-6-[T-2-(2-amino-1,4,5,6-tetrahydro-4-pyriminyl)glycine]viomycin
CBNumber:
CB41074158
Molecular Formula:
C25H43N13O10
Molecular Weight:
685.69
MDL Number:
MOL File:
33103-22-9.mol
MSDS File:
SDS
Last updated:2024-03-16 16:43:06

Enviomycin Properties

Density 1.80±0.1 g/cm3(Predicted)
pka 9.87±0.70(Predicted)
FDA UNII XU299C23A2
ATC code J04AB06

Enviomycin price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation API0013080 ENVIOMYCIN 95.00% 33103-22-9 5MG $503.72 2021-12-16 Buy
Product number Packaging Price Buy
API0013080 5MG $503.72 Buy

Enviomycin Chemical Properties,Uses,Production

Description

Enviomycin was found in the culture broth of Streptomyces griseoverticillatus var. tuberacticus by Toyo Jozo Co. in 1966 as a mixture of tuberactinomycins N and O. It is a water-soluble, basic peptide closely related to viomycin and showing selective activity against Mycobacterium species about twice as strong as that of viomycin. Enviomycin, in combination with other antituberculotic drugs, is used to treat tuberculosis caused by streptomycinresistant Mycobacterium.

Originator

Tuberactin,Toyo Jozo,Japan,1975

Manufacturing Process

Two liters of an aqueous medium consisting of glucose 3%, starch 2%, soybean meal 3% and sodium chloride 1.5% were equally divided and introduced into twenty 500-ml Erlenmeyer flasks, adjusted to pH 6, sterilized at 120°C for 30 minutes, inoculated with Streptomyces griseoverticillatus var. tuberacticus N6-130 and then rotatively shake-cultured (radius 2.5 cm, 330 rpm) at 30°C for 7 days, obtaining 1.5 liter of cultured broth containing 2,360 mcg/ml of tuberactinomycin-N.
Filtered broth was passed at 2.5 ml/min through a resin column (2.5 cm diameter, 28 cm length) packed with 150 ml of ion exchange resin Amberlite IRC-50 sodium type (Rohm and Haas Co., USA.). The column was washed with water, eluted with 0.5N HCl at a flow rate 1.3 ml/min. The eluates were fractionated each 10 ml and tuberactinomycin-N activity was found at fractions No. 45-63 observed by ultraviolet absorption method and bioassay.
The thus yielded active fraction, about 200 ml, was neutralized with sodium hydroxide, concentrated to about 15 ml in vacuo, separating the precipitated inorganic salts therefrom. After decolorization with active carbon, 150 ml of methanol was added, the mixture was allowed to stand overnight at 5°C and the precipitate was collected by filtration. The precipitate was washed withmethanol and dried in vacuo to yield crude tuberactinomycin-N hydrochloride (yield, 3.07 g; purity, 7 1.5%; recovery, 62%).

Therapeutic Function

Antitubercular

Enviomycin Preparation Products And Raw materials

Raw materials

Preparation Products

Enviomycin Suppliers

Global( 3)Suppliers
Supplier Tel Email Country ProdList Advantage
Career Henan Chemica Co
+86-0371-86658258 +8613203830695 laboratory@coreychem.com China 30241 58
Supplier Advantage
Career Henan Chemica Co
58

33103-22-9(Enviomycin)Related Search:

N2-[(4R)-4-Hydroxy-L-βLys-]cyclo[L-A2pr*-3-hydroxy-L-Ala-3-hydroxy-L-Ala-3-(carbamoylamino)Dha-2-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidine-4-yl]-L-Gly-] Tuberactinomycin N 1-(L-Threo-3,6-diamino-4-hydroxy-hexanoic acid)-6-[T-2-(2-amino-1,4,5,6-tetrahydro-4-pyriminyl)glycine]viomycin Aids008855 Aids-008855 Tuberactin (*sulfate*) Turn-n Enviomycin 1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv. enviomucin Tuberactinomycin N (8CI, 9CI) Viomycin, 1-[(3R,4R)-4-hydroxy-3,6-diaminohexanoic acid]-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]-, (R)- Cyclo[(2Z)-3-[(aminocarbonyl)amino]-2,3-didehydroalanyl-(2S)-2-[(4R)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl]glycyl-(2S)-2-[[(3R,4R)-3,6-diamino-4-hydroxy-1-oxohexyl]amino]-β-alanyl-L-seryl-L-seryl] Cyclo[(2Z)-3-[(aminocarbonyl)amino]-2,3-didehydroalanyl-(2S)-2-[(4R)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl]glycyl-(2S)-2-[[(3R,4R)-3,6-diamino-4-hydroxy-1-oxohexyl]amino]-β-alanyl-L-seryl-L-seryl] 33103-22-9